| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000008893 |
| Receipt No. | R000010433 |
| Official scientific title of the study | Japan multicenter cohort study to FIND predictors of common palliative treatments: J-FIND |
| Date of disclosure of the study information | 2012/09/11 |
| Last modified on | 2016/04/11 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Japan multicenter cohort study to FIND predictors of common palliative treatments: J-FIND | |
| Title of the study (Brief title) | J-FIND1 | |
| Region |
|
|
| Condition | |||
| Condition | Cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To identify the factors contributing to communication levels after morphine for refractory dyspnea |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase IV |
| Assessment | |
| Primary outcomes | Communication Capacity Scale |
| Key secondary outcomes | Death, Glasgow Coma Scale |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 Adult
2 Advanced cancer 3 Morphine for refractory dyspnea 4 Receivinfg specialied palliative care services 5 STAS-J of 2 or more 6 ECOG PS of 3 or 4 7 CCS of 2 or less |
|||
| Key exclusion criteria | 1 Medical contraindication to morphine
2 Drainage of pleural effusion |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Masanori Mori |
| Organization | Seirei Hamamatsu General Hospital |
| Division name | Pallaitive Medicine |
| Address | 2-12-12, Sumiyoshi, Naka-ku, Hamamatsu, Shizuoka |
| TEL | 053-474-2222 |
| Masanori.Mori@sis.seirei.or.jp | |
| Public contact | |
| Name of contact person | Masanori Mori |
| Organization | Seirei Hamamatsu General Hospital |
| Division name | Pallaitive Medicine |
| Address | 2-12-12, Sumiyoshi, Naka-ku, Hamamatsu, Shizuoka |
| TEL | 053-474-2222 |
| Homepage URL | |
| Masanori.Mori@sis.seirei.or.jp | |
| Sponsor | |
| Institute | Seirei Hamamatsu General Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Ministry of Health, Lavor and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立病院機構 大阪医療センター
大阪市立総合医療センター 大阪府立成人病センター 彩都友紘会病院 近畿中央胸部疾患センター 和歌山県立医科大学附属病院 兵庫県立がんセンター 社会保険神戸中央病院 六甲病院 藤井政雄記念病院 松江市立病院 岡山済生会総合病院 広島県立広島病院 福山市民病院 施設 国立病院機構 山口宇部医療センター 松山ベテル病院 九州がんセンター 国立病院機構 都城病院 医療法人倫生会三州病院 社会医療法人友愛会 南部病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Data collection completed |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000010433 |